Glaukos Receivables

Glaukos (GKOS) currently reports a receivables of $140M as of June 2026. That compares with $83M in the prior-year period — up 67.4% year over year. Use the charts on this page to explore Glaukos's receivables history and peer comparisons.

Glaukos's receivables increased from $83M to $140M — a 67.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Glaukos reported $140M in receivables as of June 2026. That compares with $83M in the prior-year period — up 67.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Glaukos, and consider following GKOS for alerts when major investors trade the stock.

Glaukos is classified in the Healthcare sector. On receivables, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GKOS with unrelated industries.